A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-03
DOI
10.3389/fphar.2018.01405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The NLRP3 Inflammasome Renders Cell Death Pro-inflammatory
- (2018) Moritz M. Gaidt et al. JOURNAL OF MOLECULAR BIOLOGY
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
- (2017) Mattia Cocco et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
- (2017) C. Pellegrini et al. NEUROPHARMACOLOGY
- Inflammatory Bowel Disease and the NLRP3 Inflammasome
- (2017) Thirumala-Devi Kanneganti NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
- (2017) Boris Hügle et al. Pediatric Rheumatology
- Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
- (2017) Carolina Pellegrini et al. Frontiers in Immunology
- Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
- (2016) F Martín-Sánchez et al. CELL DEATH AND DIFFERENTIATION
- NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis
- (2016) H Chung et al. CELL DEATH AND DIFFERENTIATION
- Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
- (2016) Mattia Cocco et al. ChemMedChem
- Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways
- (2016) Yazmín K. Márquez-Flores et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic
- (2016) Matteo Fornai et al. PHARMACOLOGICAL RESEARCH
- Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD
- (2015) Donata Lissner et al. INFLAMMATORY BOWEL DISEASES
- Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling
- (2015) Christina Antonopoulos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition
- (2015) Wenjie Guo et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
- (2014) Mattia Cocco et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inflammasome activation has an important role in the development of spontaneous colitis
- (2014) J Zhang et al. Mucosal Immunology
- Animal models of inflammatory bowel disease: a review
- (2014) Nidhi Goyal et al. INFLAMMOPHARMACOLOGY
- A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome
- (2013) Wen Liu et al. BIOCHEMICAL PHARMACOLOGY
- Caspase-11: The driving factor for noncanonical inflammasomes
- (2013) Elena Viganò et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Postoperative Ileus Involves Interleukin-1 Receptor Signaling in Enteric Glia
- (2013) Burkhard Stoffels et al. GASTROENTEROLOGY
- The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure
- (2012) Thomas Maslanik et al. BRAIN BEHAVIOR AND IMMUNITY
- Second-Generation Corticosteroids for the Treatment of Crohns Disease and Ulcerative Colitis: More Effective and Less Side Effects?
- (2012) Chiara De Cassan et al. DIGESTIVE DISEASES
- IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+Th17 cells
- (2012) Margherita Coccia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome
- (2012) Sonja I Gringhuis et al. NATURE IMMUNOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Inflammatory bowel disease therapy: current state-of-the-art
- (2011) Wojciech Blonski et al. CURRENT OPINION IN GASTROENTEROLOGY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
- (2010) C. Bauer et al. GUT
- The Blockade of Adenosine Deaminase Ameliorates Chronic Experimental Colitis through the Recruitment of Adenosine A2A and A3 Receptors
- (2010) L. Antonioli et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- PPAR-αContributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice
- (2010) Emanuela Esposito et al. PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now